 

   

 

 

FINAL DIAGNOSIS:

PART 1: LEFT AXILLA, SENTINEL LYMPH NODE #1, BIOPSY — / ”’0 ’ 3 1
ONE LYMPH NODE, NEGATIVE FOR TUMOR. 3W, wa due/211, m: 95 06/3
PART 2: LEFT AXILLA, SENTINEL LYMPH NODE #2, BIOPSY— 5%: W m 0501? 3/13/14 y

ONE LYMPH NODE, NEGATIVE FOR TUMOR.

PART 3: LEFT AXILLA. NONSENTINEL LYMPH NODE, BIOPSY —
ONE LYMPH NODE. NEGATIVE FOR TUMOR.

PART 4_:_LEEI_EREAS_L SEGMENTAL MASTECTOMY WITH NEEDLE LOCALIZATION —
INFILTRATING DUCTAL CARCINO 1.1 CM. NOTTINGHAM SCORE 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1).
DUCT“: CARCINOMA IN3ITU, CRIBRIFORM AND SOLID TYPES, WITH COMEDO NECROSIS REPRESENTING
10% OF THE TUMOR VOLUME.
FOCI OF DClS IS SEEN AWAY FROM THE INVASIVE TUMOR.
LYMPHOVASCULAR SPACE INVOLVEMENT IS NOT PROMINENT.
INVASIVE TUMOR IS 0.4 CM FROM THE INFERIOR MARGIN.
DUCTAL CARCINOMA lN-SITU, 0.2 CM FROM THE INFERIOR MARGIN.
MARGINS FREE OF TUMOR.
MICROCALCIFICATIONS ASSOCIATED WITH TUMOR AND BENIGN CHANGES.
FIBROCYSTIC CHANGES.
J. SKIN UNREMARKABLE.
CASE SYNOPSIS:
SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST
LATERALITY: Left
PROCEDURE: Segmental
LOCATION: Lower inner quadrant
SIZE OF TUMOR: Maximum dimension invasive component: 1.1 cm
MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI:
No
TUMOR TYPE (invasive component):
Ductal adenocarcinoma, NOS
NOTTINGHAM SCORE: Nuclear grade: 2
Tubule formation: 3
Mitotic activity score: 1

’FPF‘F'PP I”?

Total Nottingham score: 6 UUID:$é262Ac_Ega-.2Aaecgi4_2°efﬁtsksanaemia?“cted
N tt' h d 1,2, 3 : 2
ANGIOLYMPHATIC INVASION: N: mg am gm e< ) I”IIIHIIHHIIIIHIIIHIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
gifgérchwgmnc INVASION: No b . "I“"In“.Innmnmlllml'I"INIIIIIIIIIIIIIIIIIIII'IIIIIII
: es. enlgn Zones
Yes, malignant zones III IIIIIIIIIIIIIIHIIIIIIIIIIIIIIIIIIIIIIII
TUMOR TYPE, IN SITU: Cribriform
Solid
Comedo

Percent of tumor occupied by in situ component: 1O “/0
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:
NO

Distance of invasive tumor to closest margin: 4 mm
SURG MARGINS INVOLVED BY IN SITU COMPONENT:

No
Distance of in situ disease to closest margin: 2 mm
LYMPH NODES POSITIVE: 0
LYMPH NODES EXAMINED: 3
METHOD(S) OF LYMPH NODE EXAMINATION:
H/E stain
SENTINEL NODE METASTASIS: NO

SKIN INVOLVED (ULCERATION): NO
NON-NEOPLASTIC BREAST TISSUE: FCD

T STAGE, PATHOLOGIC: pT1C

N STAGE, PATHOLOGIC: pNO

M STAGE, PATHOLOGIC: pMX

ESTROGEN RECEPTORS: positive

PROGESTERONE RECEPTORS: positive 337:;in ...
HERZINEU: zero or 1+ CY

 
   
    

Primary Tumor Site Discrepam.
MIPM Discrepancy

